Role of medicinal plants in free radical induced sickle cell anemia

Sickle cell disease (SCD) is a common recessively inherited disorder of hemoglobin affecting peoples everywhere in the world. The homozygous state (SS) is associated with complications and reduced life anticipation. The symptoms including, shortness of breath, heart palpitations, abdominal pains, aches and pains in the muscle. One cause of this disease is oxidative stress which is an imbalance between the reactive oxygen species and the potential of the body to neutralize these reactive species. An anti-oxidant is a substance which prevents oxidative stress by scavenging the free radicals. Medicinal plants are good and rich sources of natural antioxidants. Crude extracts from plants have been used in treating many diseases since ancient times. Various advances in scientific research on the use of plants and herbs explore the beneficial aspects of traditional medicine. This review highlights the role of oxidative stress in the progression and development of Sickle Cell Disease (SCD) and reviews the available literature reporting antisickling properties of a number of plants extracts.

[1]  J. Butany,et al.  Pathology of sickle cell disease. , 2012, Seminars in diagnostic pathology.

[2]  B. Biemond,et al.  Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management , 2011, American journal of hematology.

[3]  T. Wellems,et al.  The impact of malaria parasitism: from corpuscles to communities. , 2009, The Journal of clinical investigation.

[4]  Ja Olagunjua,et al.  Nephroprotective activities of the aqueous seed extract of Carica papaya Linn. in carbon tetrachloride induced renal injured Wistar rats: a dose- and time-dependent study , 2009 .

[5]  R. Anandan,et al.  Protective effect of Picrorhiza kurroa on antioxidant defense status in adriamycin-induced cardiomyopathy in rats , 2007 .

[6]  M. Adaikpoh,et al.  The protective role of Scoparia dulcis on tissue antioxidant defense system of rats exposed to cadmium , 2007 .

[7]  P. Mpiana,et al.  In vitro antidrepanocytary actvity (anti-sickle cell anemia) of some congolese plants. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[8]  Aslı Semiz,et al.  Antioxidant and chemoprotective properties of Momordica charantia L. (bitter melon) fruit extract , 2007 .

[9]  P. Houghton,et al.  Anti-inflammatory activities of the methanol extracts and an isolated furanoditerpene constituent of Sphenocentrum jollyanum Pierre (Menispermaceae). , 2006, Journal of ethnopharmacology.

[10]  M. Bello,et al.  Inhibition of paracetamol-induced oxidative stress in rats by extracts of lemongrass (Cymbropogon citratus) and green tea (Camellia sinensis) in rats , 2006 .

[11]  Agarwal Mb The burden of haemoglobinopathies in India--time to wake up? , 2005 .

[12]  E. Anosike,et al.  In vitro effects of aqueous extracts of Zanthoxylum macrophylla roots on adenosine triphosphatases from human erythrocytes of different genotypes , 2005 .

[13]  D. Abraham,et al.  5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells †,‡ , 2005, British journal of haematology.

[14]  N. Orhue,et al.  Serum total protein, albumin and globulin levels in Trypanosoma brucei -infected rabbits: Effect of orally administered Scoparia dulcis , 2005 .

[15]  E. Anosike,et al.  Studies on the effect of aqueous extracts of Garcinia kola seeds on human erythrocytes adenosine triphosphatases of HbAA, HbAS and HbSS genotypes , 2004 .

[16]  T. Asakura,et al.  In vitro effects of NIPRISAN (Nix‐0699): a naturally occurring, potent antisickling agent , 2002, British journal of haematology.

[17]  J. Takasu,et al.  Aged garlic extract therapy for sickle cell anemia patients , 2002, BMC blood disorders.

[18]  C. Wambebe,et al.  Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with Sickle Cell Disorder. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[19]  C. Brugnara Reticulocyte Cellular Indices: A New Approach in the Diagnosis of Anemias and Monitoring of Erythropoietic Function , 2000, Critical reviews in clinical laboratory sciences.

[20]  M. Vanhaelen,et al.  In vitro antisickling activity of a rearranged limonoid isolated from Khaya senegalensis. , 1999, Planta medica.

[21]  F. Ohiri,et al.  Anti-sickling Potential of Terminalia catappa Leaf Extract , 1999 .

[22]  O. Platt,et al.  Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.

[23]  F. Akojie,et al.  Antisickling activity of hydroxybenzoic acids in Cajanus cajan. , 1992, Planta medica.

[24]  Y. Miwa,et al.  Antiviral agents of plant origin. III. Scopadulin, a novel tetracyclic diterpene from Scoparia dulcis L. , 1990, Chemical & pharmaceutical bulletin.

[25]  M. Iwu,et al.  Effect of cajaminose from Cajanus cajan on gelation and oxygen affinity of sickle cell haemoglobin. , 1988, Journal of ethnopharmacology.

[26]  T. Hayashi,et al.  Structure of scoparic acid A, a new labdane-type diterpenoid from a Paraguayan crude drug "Typychá Kuratũ" (Scoparia dulcis L.) , 1987, Chemical and pharmaceutical bulletin.

[27]  O. Agbai Anti-sickling effect of dietary thiocyanate in prophylactic control of sickle cell anemia. , 1986, Journal of the National Medical Association.

[28]  E. El-Desouky,et al.  Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase deficiency and mild chronic hemolysis. , 1986, The Journal of pediatrics.

[29]  F. Shode,et al.  The reversion of sickled cells by Cajanus cajan. , 1985, Planta medica.

[30]  O. Olorunsogo,et al.  Sickle-cell membrane-bound (Ca2+ + Mg2+)-ATPase: activation by 3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-6-butyric acid, a novel antisickling agent. , 1985, Cell calcium.

[31]  R. Hebbel Auto-oxidation and a membrane-associated 'Fenton reagent': a possible explanation for development of membrane lesions in sickle erythrocytes. , 1985, Clinics in haematology.

[32]  D. W. Allen,et al.  High-dose vitamin E does not decrease the rate of chronic hemolysis in glucose-6-phosphate dehydrogenase deficiency. , 1983, The New England journal of medicine.

[33]  E. Vichinsky,et al.  PEROXIDATION, VITAMIN E, AND SICKLE‐CELL ANEMIA * , 1982, Annals of the New York Academy of Sciences.

[34]  M. Sheetz,et al.  Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency. , 1980, The New England journal of medicine.

[35]  J. Mendelsohn,et al.  An examination of the role of vitamin E in glucose-6-phosphate dehydrogenase deficiency. , 1979, Clinical Biochemistry.

[36]  N. Farnsworth,et al.  Evaluation of Fagara zanthoxyloides root extract in sickle cell anemia blood in vitro. , 1975, Lloydia.

[37]  R. Carrell,et al.  Activated oxygen and haemolysis. , 1975, British journal of haematology.

[38]  V. Ingram,et al.  A Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia Hæmoglobin , 1956, Nature.